within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01X_OtherAntineoplasticAgents.L01XJ01_Vismodegib;
model Vismodegib 
   extends Pharmacolibrary.Drugs.ATC.L.L01XJ01;

  annotation(Documentation(
    info ="<html><body><p>Vismodegib is an orally administered small molecule inhibitor of the Hedgehog signaling pathway, specifically targeting the smoothened (SMO) receptor. It is approved for the treatment of adults with metastatic or locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery or radiation.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters as characterized in adult patients with advanced solid tumors, including locally advanced or metastatic basal cell carcinoma, after oral administration.</p><h4>References</h4><ol><li><p>Graham, RA, et al., &amp; Dresser, MJ (2012). Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects. <i>British journal of clinical pharmacology</i> 74(5) 788–796. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.2012.04281.x&quot;>10.1111/j.1365-2125.2012.04281.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22458643/&quot;>https://pubmed.ncbi.nlm.nih.gov/22458643</a></p></li><li><p>Abou-Alfa, GK, et al., &amp; Graham, RA (2017). Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment. <i>Cancer chemotherapy and pharmacology</i> 80(1) 29–36. DOI:<a href=&quot;https://doi.org/10.1007/s00280-017-3315-8&quot;>10.1007/s00280-017-3315-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28523596/&quot;>https://pubmed.ncbi.nlm.nih.gov/28523596</a></p></li><li><p>Frampton, JE, &amp; Basset-Séguin, N (2018). Vismodegib: A Review in Advanced Basal Cell Carcinoma. <i>Drugs</i> 78(11) 1145–1156. DOI:<a href=&quot;https://doi.org/10.1007/s40265-018-0948-9&quot;>10.1007/s40265-018-0948-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30030732/&quot;>https://pubmed.ncbi.nlm.nih.gov/30030732</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Vismodegib;
